One thousand three women with a mean age of 46 AE 15 years completed the survey. The majority was white (80%) and highly educated. Fifty-six percent were married and 73% reported !1 vaginal delivery. Nearly all (99%) reported ever being sexually active: 58% were active in the last week; 31% between 1-week and 3-years; and 11% >3-years ago. Fifty-six percent masturbated; 94% had sex with men; and 13% had sex with women. Nearly one-third (321/ 1003) had API at least once, while fewer considered it "part of their sexual practice" (12%) or engaged in it in the last year (13%). Similarly, 4% considered anal plug use to be a "part of their sexual practice," but 7% had tried it at least once (Table 1) . Of women who had API, 56% reported it was for their partner's pleasure, 29% for their own pleasure, and one to maintain her virginity. API was associated with sexual activity with women (p ¼ 0.002), but not with age, race or marital status. Sixty percent reported a bothersome urinary symptom on the UDI6 and 70% reported anal incontinence on the FISI. Following vaginal intercourse, nineteen percent had changes in bladder function and 14% had dyspareunia. API was more common among women who reported these changes in bladder function with vaginal intercourse (44%% vs 30%, p < 0.001) and in those with dyspareunia (17% vs 12%, p ¼ 0.05). Of women who engaged in API, 18% reported that it changed their stool caliber and 10% reported that it caused anal incontinence ( Table 2 ). Higher FISI scores were associated with API in the past month (p ¼ 0.05). CONCLUSION: Overall, API is common in women, especially those with pelvic floor symptoms. Self-reported anal incontinence and FISI scores are higher in women who have had API, suggesting that it influences a woman's continence mechanisms.
OBJECTIVES: Previous studies have demonstrated that differences in medical practice across regions of the United States account for substantial differences in cost of care for the same type of procedure or treatment. Hysterectomy is one of the most common procedures performed in the United States, with over 400,000 surgeries performed annually, accounting for approximately $5 billion in health care spending. While prior studies have assessed the cost of hysterectomy, they have primarily focused on the effect that the mode of hysterectomy has on cost. The goal of this study is to evaluate whether the geographic region where a hysterectomy is performed accounts for differences in cost when controlling for confounding factors.
MATERIALS AND METHODS:
We utilized the 2013 National Inpatient Sample (NIS) from the Healthcare Cost and Utilization Project (HCUP) to collect data on total charges, concomitant procedures, primary diagnosis, and length of stay, patient demographics, and hospital location. The primary outcome was higher cost defined as cost above the median (>50th percentile). ICD-9 procedure codes were used to identify patients who underwent laparoscopic, laparoscopic assisted (LAVH), robotic, abdominal, and vaginal hysterectomy and concurrent vaginal reconstruction, anti-incontinence, surgery, adhesiolysis, bilateral and unilateral salpingooophorectomy, cystoscopy. Additional co-variables included the primary admitting diagnosis, and demographic factors. Inclusion criteria included age over 18 years and benign indication for hysterectomy. Patients who had incomplete data, were under the age of 18, or had a diagnosis of malignancy were excluded. The total hospital charges were converted to total cost using the HCUP cost-to-charge ratio. Stepwise multivariate regression analysis was used to evaluate the effect of co-variables on cost of hysterectomy. Statistical analysis was performed using JMP 10 (SAS, Carey NC). RESULTS: A total of 38,414 hysterectomies were identified, of these 17.1% were laparoscopic, 11.2% were robotic, 58% were abdominal, and 14.2% were vaginal. The median length of stay was 2 days (IQR: 1-3), median age was 46 years (IQR: 41-52) and the median cost of hysterectomy $13,981 (IQR: 9,075-21,977). Table 1 demonstrates the median cost of hysterectomy by region. The mid-Atlantic region had the lowest median cost $9,661 (IQR: 6,243-15,335) and the Pacific region was associated with the highest cost $22,534 (IQR: 15,380-33,797) ( Table 1 ). For every 10 years increase an age there was a 4.0% incremental increase in odds of greater than median cost of hysterectomy (OR ¼ 1.004, p < 0.0001). For every day of admission there was an 88% incremental increase in odds of greater than median cost (OR ¼1.88, p < 0.001). The Pacific region was associated with the highest odds for higher cost (OR ¼ 10.4, p < 0.001) compared to Mid-Atlantic. Robotic hysterectomy was associated with the highest odds for higher cost (OR ¼ 6.1, p < 0.001) compared to vaginal hysterectomy ( 
OBJECTIVES:
To describe the anatomic and symptomatic outcomes of women treated with abdominal sacrohysteropexy (ASH).
MATERIALS AND METHODS:
We performed a retrospective chart review with prospective physical examination and quality of life measures for women who have undergone ASH. The ASH was performed at a single institution by a board certified Urogynecologist. All patients had a piece of hand tailored Gynemesh affixed to the posterior vaginal wall and sacral promontory. Women who had completed childbearing had a second piece of Gynemesh affixed to the anterior vaginal wall, passed through a window created in the broad ligament, and affixed to the sacral promontory. For women who were uncertain or desired future childbearing, the anterior dissection was not performed. Postoperative pelvic examinations were performed by a Urogynecology fellow independently of the surgeon who performed the surgical procedures, including supine POP-Q and standing examinations. Quality of life was assessed with the Incontinence Impact Questionnaire-7 (IIQ-7), the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12), and Pelvic Floor Distress Inventory-Short Form 20 (PFDI-20). RESULTS: Sixteen patients underwent ASH between 2006 and 2012 and met inclusion criteria. Thirteen women (81.3%) were available for follow-up. At baseline, all patients had a presenting complaint of pelvic organ prolapse, 6 reported stress urinary incontinence, and 2 reported mixed urinary incontinence. At initial presentation, mean (standard deviation [SD]) BMI was 26.6 (5.7). The number of patients in prolapse stages were: apical stage 0-I: 1, apical II-III: 12; anterior 0-I: 2, anterior II-III: 11; posterior 0-I: 2, posterior II-III: 11. Mean (SD) operating time was 141 (36) minutes, average (SD) estimated blood loss was 114 (48) milliliters. Mean follow-up time was 40.9 (17.7) months. Postoperatively, mean (SD) BMI was 28.1 (5.9). The number of patients in prolapse stages were: apical stage 0-I: 13, apical II-III: 0; anterior 0-I: 10, anterior II-III: 2; posterior 0-I: 13, posterior II-III: 0. All stages were statistically significantly improved from preoperative staging. Postoperatively, 2 patients had a stage II cystocele, but both were asymptomatic. One patient had anterior wall mesh erosion, which was treated successfully with estrogen cream. Three patients had attempted pregnancy. At the time of follow-up, one patient had carried to term, and delivered via uncomplicated cesarean section. Another was 12 weeks pregnant. The last was attempting to get pregnant, although HSG demonstrated lack of dye spillage from a fallopian tube. Average (SD) PISQ-12, PFDI-20, and IIQ-7 scores were 37.6 (4.7), 38.6 (43.9), and 1.1 (2.5), respectively. CONCLUSION: Our study presents optimistic anatomic and symptomatic results from ASH. At an average of 40.9 months postoperatively, none of the thirteen patients had required further evaluation for prolapse or incontinence. Two of three patients who desired childbearing were able to achieve pregnancy, and one delivered via uncomplicated cesarean section. All quality of life post-operative scores indicated a high quality of life.
